The Policy and Financial Pressures Reshaping Patient Access in 2026 and Beyond

Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawAbout 1 in 4 patients admit that an out-of-pocket cost of just $50 to $100 may be enough to stop them from starting a newly prescribed therapy, according to the latest Peer Engagement Survey from Nuvera Life Science Consulting presented at InformaConnect Patient Assistance and Access Programs meeting, in Philadelphia, in March 2026.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding: